Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, UsA.
AJR Am J Roentgenol. 2010 Jun;194(6):W464-70. doi: 10.2214/AJR.09.3843.
The purpose of this article is to review the role of FDG PET/CT in ovarian cancer, which is the leading cause of death among gynecologic cancers.
FDG PET/CT can significantly modify the assessment of the extent of primary and recurrent ovarian cancer and, hence, often alters patient management substantially. FDG PET/CT has thus become a critical tool for the preoperative evaluation of women with primary ovarian cancer and for postoperative follow-up assessment for evidence of recurrence in these patients.
本文旨在回顾 FDG PET/CT 在卵巢癌中的作用，卵巢癌是妇科癌症死亡的主要原因。
FDG PET/CT 可显著改变原发性和复发性卵巢癌的评估范围，因此通常会显著改变患者的管理方式。因此，FDG PET/CT 已成为原发性卵巢癌术前评估以及这些患者术后随访评估复发证据的重要工具。
